Michal Inbar-Feigenberg, McGill University

Research

Growth Mucopolysaccharidoses Pain Quality Of Life Rare Disease Tnf-Alpha

Latest funding

The Safety and Efficacy of Adalimumab for Pain Reduction in Individuals with Mucopolysaccharidoses: A Phase 1/2 Randomized, Double-Blind, Placebo-Controlled Trial
CIHR · 2022 · Principal investigator
$293,643
The Safety and Efficacy of Adalimumab for Pain Reduction in Individuals with Mucopolysaccharidoses: A Phase 1/2 Randomized, Double-Blind, Placebo-Controlled Trial
CIHR · 2022 · Principal investigator
$1,174,568

The Safety and Efficacy of Adalimumab for Pain Reduction in Individuals with Mucopolysaccharidoses: A Phase 1/2 Randomized, Double-Blind, Placebo-Controlled Trial

Principal investigatorCIHR2022Operating Grant: Clinical Trials Projects - Indirect Costs

Principal investigators: Mitchell, John J; Smith, Maureen M; Inbar-Feigenberg, Michal; Jain, Shailly; Polgreen, Lynda; Potter, Elizabeth K

Keywords: Growth; Mucopolysaccharidoses; Pain; Quality Of Life; Rare Disease; Tnf-Alpha

$293,643

The Safety and Efficacy of Adalimumab for Pain Reduction in Individuals with Mucopolysaccharidoses: A Phase 1/2 Randomized, Double-Blind, Placebo-Controlled Trial

Principal investigatorCIHR2022Operating Grant: Clinical Trials Projects-Canadian sites of international trials

Principal investigators: Mitchell, John J; Smith, Maureen M; Inbar-Feigenberg, Michal; Jain, Shailly; Polgreen, Lynda; Potter, Elizabeth K

Keywords: Growth; Mucopolysaccharidoses; Pain; Quality Of Life; Rare Disease; Tnf-Alpha

$1,174,568

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2022

Subject: Prospective PhD student: Growth Dear Professor Inbar-Feigenberg, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on growth connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "The Safety and Efficacy of Adalimumab for Pain Reduction in Individuals with Mucopolysaccharidoses: A Phase 1/2 Randomized, Double-Blind, Placebo-Controlled Trial" (2022), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]